However, deletion of islet TCF7L2 expression from β-cells did not show any demonstrable effects on glucose-stimulated insulin secretion (GSIS) in adult mice, whereas manipulating TCF7L2 levels in the liver caused hypoglycemia and reduced hepatic glucose production [133]. The gene discussed is TCF7L2; the disease is Hypoglycemia.